Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Fidelity National Information Services
FIS
|
$513M |
| 2 |
Medtronic
MDT
|
$497M |
| 3 |
Apple
AAPL
|
$432M |
| 4 |
L3Harris
LHX
|
$340M |
| 5 |
Danaher
DHR
|
$254M |
Top Sells
| 1 |
Mastercard
MA
|
$427M |
| 2 |
AbbVie
ABBV
|
$387M |
| 3 |
LLL
L3 Technologies, Inc.
LLL
|
$315M |
| 4 |
CoStar Group
CSGP
|
$270M |
| 5 |
Abbott
ABT
|
$258M |
Sector Composition
| 1 | Technology | 25.79% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 12.76% |
| 4 | Industrials | 11.55% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Intel
INTC
$105B
| $563M | 0.31% |
10,930,758
+1,735,487
| +19% | +$89.4M |
|
77
Johnson & Johnson
JNJ
$429B
| $560M | 0.3% |
4,331,666
+344,635
| +9% | +$44.6M |
|
78
LyondellBasell Industries
LYB
$17.4B
| $557M | 0.3% |
6,221,336
+343,792
| +6% | +$30.8M |
|
79
IQVIA
IQV
$31.4B
| $553M | 0.3% |
3,700,180
+69,541
| +2% | +$10.4M |
|
80
Honeywell
HON
$136B
| $536M | 0.29% |
3,170,430
+331,440
| +12% | +$56.1M |
|
81
Revvity
RVTY
$9.68B
| $528M | 0.29% |
6,197,979
-70,118
| -1% | -$5.97M |
|
82
JPMorgan Chase
JPM
$824B
| $527M | 0.29% |
4,479,404
-273,737
| -6% | -$32.2M |
|
83
W.R. Berkley
WRB
$27.4B
| $518M | 0.28% |
7,175,899
+69,184
| +1% | +$5M |
|
84
Amdocs
DOX
$9.31B
| $512M | 0.28% |
7,738,712
+24,453
| +0.3% | +$1.62M |
|
85
Euronet Worldwide
EEFT
$3.72B
| $508M | 0.28% |
3,469,574
+155,221
| +5% | +$22.7M |
|
86
Deere & Co
DE
$127B
| $499M | 0.27% |
2,957,976
+176,809
| +6% | +$29.8M |
|
87
Cimpress
CMPR
$1.49B
| $498M | 0.27% |
3,780,948
-4,562
| -0.1% | -$601K |
|
|
88
Medtronic
MDT
$118B
| $497M | 0.27% |
+4,571,875
| New | +$497M |
|
89
Sensata Technologies
ST
$4.63B
| $496M | 0.27% |
9,909,768
-1,973,871
| -17% | -$98.8M |
|
90
Edwards Lifesciences
EW
$47.7B
| $494M | 0.27% |
2,248,567
-205,336
| -8% | -$45.2M |
|
91
Humana
HUM
$37.5B
| $492M | 0.27% |
1,923,063
-240,841
| -11% | -$61.6M |
|
92
Crown Holdings
CCK
$10.7B
| $475M | 0.26% |
7,182,987
+419,153
| +6% | +$27.7M |
|
|
DNKN
93
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $471M | 0.26% |
5,931,479
-426,476
| -7% | -$33.8M |
|
94
Constellation Brands
STZ
$25.8B
| $467M | 0.25% |
2,251,815
-111,550
| -5% | -$23.1M |
|
95
ICU Medical
ICUI
$3.06B
| $458M | 0.25% |
2,868,241
+42,405
| +2% | +$6.77M |
|
96
American Express
AXP
$225B
| $455M | 0.25% |
3,848,228
+573,304
| +18% | +$67.8M |
|
97
General Dynamics
GD
$86.8B
| $452M | 0.25% |
2,475,100
+139,141
| +6% | +$25.4M |
|
98
Hilton Worldwide
HLT
$64.7B
| $447M | 0.24% |
4,804,287
+215,986
| +5% | +$20.1M |
|
99
Elevance Health
ELV
$72.4B
| $446M | 0.24% |
1,857,524
-331,988
| -15% | -$79.7M |
|
100
Blackbaud
BLKB
$3.23B
| $441M | 0.24% |
4,882,552
+3,646
| +0.1% | +$329K |
|